116907-30-3 Usage
General Description
1,3-Dioxolan-4-one, 2-(1,1-dimethylethyl)-5-phenyl-, (2R,5R)- is a chemical compound that is also known by the trade name Ropivacaine. It is a local anesthetic that is used for various medical procedures and surgeries to numb the sensation of pain in a specific area of the body. It works by blocking the transmission of pain signals along nerves. Ropivacaine is often used in epidurals, nerve blocks, and other types of regional anesthesia. It is considered to be a safer alternative to other local anesthetics due to its lower potential for causing cardiac and central nervous system toxicity. However, like all medications, it carries the risk of side effects and should only be used under the supervision of a qualified healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 116907-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,9,0 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 116907-30:
(8*1)+(7*1)+(6*6)+(5*9)+(4*0)+(3*7)+(2*3)+(1*0)=123
123 % 10 = 3
So 116907-30-3 is a valid CAS Registry Number.
116907-30-3Relevant articles and documents
Convenient synthesis of O-functionalized mandelic acids via Lewis acid mediated transformation of 1,3-dioxolan-4-ones
Shcherbinin, Vitaly A.,Konshin, Valery V.
, p. 3570 - 3578 (2019/05/24)
An efficient method for the synthesis of O-substituted mandelic acids containing alkenyl, alkynyl, methoxycarbonyl, or phenacyl fragments via the Lewis acid-catalyzed reaction of 1,3-dioxolan-4-ones with different C-nucleophiles is proposed.
A quaternary ammonium salt of pentethyl quinamidine optical isomer, pharmaceutical composition and its medical use
-
Paragraph 0077-0078, (2017/02/24)
The invention relates to a quaternary ammonium salt compound shown as a formula I, or pharmaceutically acceptable salt or solvate thereof. The invention also relates to application of the compound as a selective M receptor antagonist, particularly a selec
Guanidine-containing compounds useful as muscarinic receptor antagonists
-
Page/Page column 18, (2009/04/24)
The invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein R1-3, R5-7, a, X, Y, Y′, Y″, and Z are as defined in the specification. These compounds are muscarinic receptor antagonists. The in
